The global burden of IPF is expected to rise, due to the rapidly aging population of Asia Pacific region, with South Korea, in particular, having the highest incidence and prevalence rates of IPF.
Novotech Identifies Decentralized Clinical Trials Potential and Challenges for Accelerating Global…
Hong Kong - Novotech, the leading Asia P
Read more